Click here to buy the human growth hormone product recommended by EternalHGH.com.
Kerstin Albertsson-Wikland, A. Stefan Aronson, Jan Gustafsson, Lars Hagenäs,
Sten A. Ivarsson, Björn Jonsson, Berit Kriström, Claude Marcus, Karl Olof
Nilsson, E. Martin Ritzén, Torsten Tuvemo, Otto Westphal, and Jan Åman
Journal of Clinical Endocrinology & Metabolism, 2008; 93 (11): 4342
doi:10.1210/jc.2008-0707
The purpose of this twenty year randomized, controlled study was to
investigate the effect on growth to final height (FH) of two different daily
growth hormone (GH) doses given to short children. The effect of GH therapy
in short non-GH-deficient children, especially those with idiopathic short
stature (ISS), has not been clearly established owing to the lack of
controlled trials continuing until final height.
This long-term multicenter study was conducted in Sweden and
included 171 prepubertal children, most with idiopathic short stature, who
were followed to final height. These children were randomized to receive no
treatment, low GH dosage (33 µg/kg·d), or high GH dosage (67 µg/kg·d). The
researchers measured final height standard deviations scores (SDS),
difference in SDS to mid-parental height, and gain in height.
Those children treated with GH had a mean height gain of more than
three inches (1.3 SDS), with some cases seeing a gain of nearly eight inches
(3 SDS). The study also found no serious adverse effects and no impact on
onset of puberty. Children with parents of normal height responded better to
treatment than those with short parents.
The study concluded the growth hormone treatment significantly
increased final height in children with idiopathic short stature, in a
dose-dependent manner, as compared to the untreated controls.
Start your all natural hGH supplemementation today. Click here to get started.
Hgh Research Paper Index
HGH Articles